Compounds > 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Nephrotic Syndrome

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Nephrotic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, T; Fukatsu, A; Hara, T; Kakumu, S; Kusunoki, M; Minami, A; Miyata, T; Nakamura, T; Nakaya, Y; Nakayama, K; Ohnaka, M; Okada, K; Sakamoto, S; Tsutsumi, K1

Other Studies

1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Nephrotic Syndrome

ArticleYear
Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:5

    Topics: Animals; Benzamides; Blood Urea Nitrogen; Cholesterol, HDL; Doxorubicin; Hypolipidemic Agents; Kidney; Lipids; Lipoprotein Lipase; Male; Nephrotic Syndrome; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley

2000